{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:03:35Z","timestamp":1790186615211,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jns.2026.126162","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:41:25Z","timestamp":1788565285000},"page":"126162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glial fibrillary acidic protein in progressive supranuclear palsy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"490","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-8354","authenticated-orcid":false,"given":"Giuseppe","family":"Magro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Laterza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mechelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Tosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Camastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jns.2026.126162_bb0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jns.2026.126162_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.jns.2026.126162_bb0015","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2026.126162_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jnnp-2017-315857","article-title":"Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers","volume":"88","author":"Jabbari","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214406","article-title":"Plasma pTau217 and neurofilament light chain as differentiative markers for progressive supranuclear palsy from Parkinson disease","volume":"106","author":"Li","year":"2026","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00415-025-13570-7","article-title":"Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy","volume":"273","author":"Lee","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.126162_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123617","article-title":"The role of blood-based biomarkers in parkinsonian disorders, Alzheimer\u2019s disease and frontotemporal dementia","volume":"476","author":"Campagnolo","year":"2025","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2026.126162_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jns.2026.126162_bb0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","article-title":"Neuroinflammation predicts disease progression in progressive supranuclear palsy","volume":"92","author":"Malpetti","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jns.2026.126162_bb0055","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/ana.25911","article-title":"Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy","volume":"88","author":"Malpetti","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126162_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"15","key":"10.1016\/j.jns.2026.126162_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157191","article-title":"From acute injury to chronic neurodegeneration: molecular mechanisms linking secondary brain injury to long-term pathology","volume":"26","author":"Kaniuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2026.126162_bb0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/neup.12143","article-title":"Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration","volume":"34","author":"Yoshida","year":"2014","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/neup.12590","article-title":"Chameleons and mimics: progressive supranuclear palsy and corticobasal degeneration","volume":"40","author":"Mimuro","year":"2020","journal-title":"Neuropathology"},{"issue":"4","key":"10.1016\/j.jns.2026.126162_bb0080","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00401-002-0569-x","article-title":"Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process","volume":"104","author":"Togo","year":"2002","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.jns.2026.126162_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-001-0488-2","article-title":"Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration","volume":"103","author":"Piao","year":"2002","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jns.2026.126162_bb0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mds.29339","article-title":"Plasma biomarkers and positron emission tomography tau pathology in progressive supranuclear palsy","volume":"38","author":"Huang","year":"2023","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2026.126162_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.26962","article-title":"In vivo assessment of astrocyte reactivity in patients with progressive supranuclear palsy","volume":"96","author":"Hirata","year":"2024","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1877718X241298192","article-title":"Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism","volume":"15","author":"Li","year":"2025","journal-title":"J. Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.jns.2026.126162_bb0105","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00702-025-03091-y","article-title":"Distinct plasma inflammatory signatures reflect disease severity and progression in progressive supranuclear palsy: a prospective cohort study","volume":"133","author":"Kim","year":"2026","journal-title":"J. Neural Transm."},{"issue":"12","key":"10.1016\/j.jns.2026.126162_bb0110","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/mds.28738","article-title":"Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2026.126162_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","article-title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy","volume":"93","author":"Chouliaras","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"3","key":"10.1016\/j.jns.2026.126162_bb0125","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration","volume":"77","author":"Benussi","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.jns.2026.126162_bb0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jns.2026.126162_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.118784","article-title":"Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: a multicenter cohort study","volume":"558","author":"Chen","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson\u2019s disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.jns.2026.126162_bb0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/mds.22895","article-title":"Differential pattern of brain-specific CSF proteins tau and amyloid-\u03b2 in parkinsonian syndromes","volume":"25","author":"S\u00fcssmuth","year":"2010","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2026.126162_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2026.126162_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119975","article-title":"Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease","volume":"565","author":"Chen","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.jns.2026.126162_bb0160","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2022.3265","article-title":"Distinguishing frontotemporal lobar degeneration tau from TDP-43 using plasma biomarkers","volume":"79","author":"Cousins","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126162_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-025-01712-y","article-title":"Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer\u2019s disease and other neurodegenerative dementias in a large Chinese cohort","volume":"17","author":"Jiao","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"3","key":"10.1016\/j.jns.2026.126162_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70116","article-title":"Novel blood-based proteomic signatures across multiple neurodegenerative diseases","volume":"21","author":"Durcan","year":"2025","journal-title":"Alzheimers Dement."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:18:40Z","timestamp":1790183920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26004442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":34,"alternative-id":["S0022510X26004442"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126162","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glial fibrillary acidic protein in progressive supranuclear palsy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126162"}}